Galmed Pharmaceuticals (GLMD) Retained Earnings (2013 - 2025)
Galmed Pharmaceuticals (GLMD) recorded quarterly Retained Earnings of -$303000.0 in Q4 2025, up 4.11% quarter-over-quarter from -$316000.0 in Q3 2025, and up 99.85% on a YoY basis from -$151614.6 in Q4 2024.
Galmed Pharmaceuticals (GLMD) Retained Earnings (2013 - 2025) Analysis & Trends
Galmed Pharmaceuticals' Retained Earnings history runs 13 years deep, the most recent figure standing at -$303000.0 for Q4 2025.
- In Q4 2025, Retained Earnings rose 99.85% year-over-year to -$303000.0; the TTM figure through Dec 2025 stood at -$303000.0 (up 99.85% YoY), while the FY2025 annual figure was -$303000.0, up 99.85% from the prior year.
- Retained Earnings was -$303000.0 for Q4 2025 at Galmed Pharmaceuticals, up from -$316000.0 in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of $347000.0 in Q3 2021 to a low of -$200.5 million in Q4 2024.
- Historically, Retained Earnings has averaged -$34.2 million across 5 years, with a median of -$531000.0 in 2023.
- The sharpest annual moves came in 2021 and 2024: Retained Earnings surged 100.28% in 2021, then slumped 44056.17% in 2024.
- A 5-year view of Retained Earnings shows it stood at -$171000.0 in 2021, then tumbled by 335.67% to -$745000.0 in 2022, then surged by 39.06% to -$454000.0 in 2023, then plunged by 44056.17% to -$200.5 million in 2024, then jumped by 99.85% to -$303000.0 in 2025.
- The last three Retained Earnings figures came in at -$303000.0 (Q4 2025), -$316000.0 (Q3 2025), and -$403000.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | -153.89 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -211.85 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.00 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 130.89 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -279.00 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -1.88 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 14.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -838.07 Mn |
| 10 | Galmed Pharmaceuticals | 2.48 Mn | -1.63 Mn | - | -303,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -303,000.00 |
| Sep 30, 2025 | -316,000.00 |
| Jun 30, 2025 | -403,000.00 |
| Mar 31, 2025 | -397,000.00 |
| Dec 31, 2024 | -200.47 Mn |
| Sep 30, 2024 | -342,000.00 |
| Jun 30, 2024 | -435,000.00 |
| Mar 31, 2024 | -455,000.00 |
| Dec 31, 2023 | -454,000.00 |
| Sep 30, 2023 | -607,000.00 |
| Jun 30, 2023 | -662,000.00 |
| Mar 31, 2023 | -4.06 Mn |
| Dec 31, 2022 | -745,000.00 |
| Sep 30, 2022 | -876,000.00 |
| Jun 30, 2022 | -982,000.00 |
| Mar 31, 2022 | -174.32 Mn |
| Dec 31, 2021 | -171,000.00 |
| Sep 30, 2021 | 347,000.00 |
| Jun 30, 2021 | -153.01 Mn |
| Mar 31, 2021 | -144.61 Mn |